Related Experiment Video
Updated: Nov 11, 2025

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
Immune responses and exacerbations in severe asthma.
Matthew J Camiolo1, Sagar L Kale1, Timothy B Oriss1
1Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Severe asthma is difficult to treat and involves more than just the Type 2 (T2) immune response. New research highlights additional immune factors and cytokines, like IFN-γ, contributing to severe asthma and exacerbations.
Area of Science:
- Immunology
- Pulmonology
- Genetics
Background:
- Asthma severity varies widely, with severe cases poorly responsive to standard inhaled corticosteroids.
- Current understanding suggests Type 2 (T2) immune responses are key, but other factors are involved in severe asthma pathogenesis.
Purpose of the Study:
- To review the complex molecular and immunologic factors contributing to severe asthma.
- To explore subphenotypes and endotypes of asthma based on immune pathways.
- To discuss the role of non-T2 cytokines and epithelial mediators in severe asthma and exacerbations.
Main Methods:
- Review of transcriptomic data and patient characteristics.
- Analysis of patient response to biologic therapies.
- Integration of data on T2 and non-T2 immune pathways.
Main Results:
- Severe asthma involves additional molecular and immunologic factors beyond the T2 immune response.
- Distinct asthma subphenotypes and endotypes may exist with varying responses to therapies.
- Non-T2 cytokines (e.g., IFN-γ) and epithelial mediators are associated with severe asthma.
Conclusions:
- Understanding diverse immune pathways is crucial for classifying asthma endotypes.
- Identifying non-T2 pathways offers potential for novel therapeutic targets in severe asthma.
- Further research into these pathways may improve management of acute asthma exacerbations.
Related Concept Videos
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-I: Introduction
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:

